sex and familial morbidity. Acta Psychiatr Scand. 1994; 89(2): 135–41
448
Brugha T, Singleton N, Meltzer H, et al. Psychosis in the community and in prisons: a report from the British National Survey of psychiatric morbidity. Am J Psychiatry. 2005; 162(4): 774–80
449
Ostling S, Skoog I. Psychotic symptoms and paranoid ideation in a nondemented population-based sample of the very old. Arch Gen Psychiatry. 2002; 59(1): 53–9
450
Лаувенг А. Завтра я всегда бывала львом. – М.: Бахрах-М, 2012
451
Trémeau F, Antonius D, Cacioppo JT, et al. In support of Bleuler: objective evidence for increased affective ambivalence in schizophrenia based upon evocative testing. Schizophr Res. 2009; 107(2–3): 223–31
452
De Clerambault, Psychoses a base d'automatisme (1925), La Psychiatrie, 1994: 511
453
Kiran C, Chaudhury S. Understanding delusions. Industrial Psychiatry Journal. 2009; 18(1): 3–18
454
О'Брайен Б. Необыкновенное путешествие в безумие и обратно: Операторы и вещи. – М.: Класс, 1996
455
Steven M. Silverstein, Adriann Lai: The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update. Front. Psychiatry, 11 June 2021.
456
Byrne P. Managing the acute psychotic episode. BMJ: British Medical Journal. 2007; 334(7595): 686–692
457
Van rensburg AB, Olorunju S. Diagnosis and treatment of schizophrenia in a general hospital based acute psychiatric ward. Afr J Psychiatry (Johannesbg). 2010; 13(3): 204–10
458
Surviving Schizophrenia: A Manual for Families, Patients, and Providers (5th Edition) by E. Fuller Torrey (Author), Publisher: Quill; 5th edition (April 1, 2006).
459
Mitchison A., Kim Noble: The woman with 100 personalities, The Guardian, 30 September 2011
460
Nathan PE, Gorman JM. A Guide to Treatments that Work. Oxford University Press, USA; 2007: 463–5
461
Beidel DC, Frueh BC, Hersen M. Adult Psychopathology and Diagnosis. John Wiley & Sons; 2014.
462
Korol S. Familial and social support as protective factors against the development of dissociative identity disorder. J Trauma Dissociation. 2008; 9(2): 249–67
463
Gillig PM. Dissociative identity disorder: a controversial diagnosis. Psychiatry (Edgmont). 2009; 6(3): 24–9.
464
Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012; 25(3): 367–82
465
Burns A, Iliffe S. Dementia. BMJ. 2009; 338: b75
466
Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007; 6(11): 994–1003
467
O'donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum Mol Genet. 2003; 12 Spec № 2: R125–33
468
Torrey EF. Surviving Schizophrenia, 6th Edition, A Family Manual. Harper Perennial; 2013: 135
469
Van os J, Kapur S. Schizophrenia. Lancet. 2009; 374(9690): 635–45
470
Cardno AG, Marshall EJ, Coid B, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry. 1999; 56(2): 162–8
471
Kendler KS, Mcguire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry. 1993; 50(7): 527–40
472
O'Donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum Mol Genet. 2003; 12 Spec № 2: R125–33
473
Torrey EF, Yolken RH. Psychiatric Genocide: Nazi Attempts to Eradicate Schizophrenia. Schizophrenia Bulletin. 2010; 36(1): 26–32
474
Crow TJ. Schizophrenia as the price that homo sapiens pays for language: a resolution of the central paradox in the origin of the species. Brain Res Brain Res Rev. 2000; 31(2–3): 118–29
475
Burns JK. An evolutionary theory of schizophrenia: cortical connectivity, metarepresentation, and the social brain. Behav Brain Sci. 2004; 27(6): 831–55
476
Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III – the final common pathway. Schizophr Bull. 2009; 35(3): 549–62
477
Carlsson A., Carlsson ML. Dopaminergic stabilisers. Adv Schizophrenia and Clin Psychiatry. 2005; 1: 118–128
478
Da silva alves F, Figee M, Van amelsvoort T, Veltman D, De haan L. The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication. Psychopharmacol Bull. 2008; 41(1): 121–32
479
Pogarell O, Koch W, Karch S, et al. Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms. Pharmacopsychiatry, 2012; 45 Suppl 1: S36–41
480
Mechri A, Saoud M, Khiari G, D'amato T, Dalery J, Gaha L. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Encephale. 2001; 27(1): 53–9
481
Reynolds LM, Cochran SM, Morris BJ, Pratt JA, Reynolds GP. Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain. Schizophr Res. 2005; 73(2–3): 147–52
482
Coyle JT. NMDA receptor and schizophrenia: a brief history. Schizophr Bull. 2012; 38(5): 920–6
483
Upthegrove, R., & Khandaker, G. M. (2020). Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia. Current topics in behavioral neurosciences, 44, 49–66. https://doi.org/10.1007/7854_2018_88.
484
Richard A, Churan J, Whitford V, O'driscoll GA, Titone D, Pack CC. Perisaccadic perception of visual space in
